UBS Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $205M | Buy |
|
|||||
|
2025
Q2 | $128M | Buy |
|
|||||
|
2025
Q1 | $99.5M | Sell |
|
|||||
|
2024
Q4 | $127M | Buy |
|
|||||
|
2024
Q3 | $114M | Buy |
|
|||||
|
2024
Q2 | $130M | Buy |
|
|||||
|
2024
Q1 | $98.3M | Buy |
|
|||||
|
2023
Q4 | $57.1M | Sell |
|
|||||
|
2023
Q3 | $57.1M | Buy |
|
|||||
|
2023
Q2 | $39.1M | Sell |
|
|||||
|
2023
Q1 | $42.9M | Sell |
|
|||||
|
2022
Q4 | $39.5M | Sell |
|
|||||
|
2022
Q3 | $29.6M | Buy |
|
|||||
|
2022
Q2 | $28.3M | Sell |
|
|||||
|
2022
Q1 | $35.4M | Sell |
|
|||||
|
2021
Q4 | $37.3M | Buy |
|
|||||
|
2021
Q3 | $31.5M | Sell |
|
|||||
|
2021
Q2 | $28.5M | Sell |
|
|||||
|
2021
Q1 | $30.2M | Buy |
|
|||||
|
2020
Q4 | $31M | Sell |
|
|||||
|
2020
Q3 | $32.2M | Buy |
|
|||||
|
2020
Q2 | $30.3M | Buy |
|
|||||
|
2020
Q1 | $25.6M | Sell |
|
|||||
|
2019
Q4 | $25.4M | Sell |
|
|||||
|
2019
Q3 | $22.8M | Sell |
|
|||||
|
2019
Q2 | $34.8M | Buy |
|
|||||
|
2019
Q1 | $28.9M | Sell |
|
|||||
|
2018
Q4 | $26.2M | Sell |
|
|||||
|
2018
Q3 | $28.5M | Buy |
|
|||||
|
2018
Q2 | $26M | Sell |
|
|||||
|
2018
Q1 | $31.3M | Sell |
|
|||||
|
2017
Q4 | $38.3M | Buy |
|
|||||
|
2017
Q3 | $30.6M | Buy |
|
|||||
|
2017
Q2 | $27.1M | Buy |
|
|||||
|
2017
Q1 | $19.5M | Buy |
|
|||||
|
2016
Q4 | $14.3M | Sell |
|
|||||
|
2016
Q3 | $16.6M | Sell |
|
|||||
|
2016
Q2 | $22M | Sell |
|
|||||
|
2016
Q1 | $22.9M | Sell |
|
|||||
|
2015
Q4 | $29.8M | Buy |
|
|||||
|
2015
Q3 | $26.6M | Buy |
|
|||||
|
2015
Q2 | $23.2M | Sell |
|
|||||
|
2015
Q1 | $24.3M | Sell |
|
|||||
|
2014
Q4 | $22.2M | Buy |
|